               SEQUENCE LISTING

<110> DSM IP Assets B.V.

<120> METHOD OF CROSS-LINKING BIOMATERIAL WITH A POLYFUNCTIONAL AZIRIDINE COMPOUND AND PRODUCTS OBTAINED THEREWITH

<130> 33643-WO-PCT

<140> PCT/2021/051386
<141> 2021-01-21

<150> EP20153209.0
<151> 2020-01-22

<160> 20

<170> BiSSAP 1.3.6

<210> 1
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<223> Function as suggested in the description, page 12 in the table,
      row 1

<400> 1
Gly Arg Gly Asp Ser 
1               5   

<210> 2
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Function as suggested in the description, page 12 in the table,
      row 1

<400> 2
Arg Gly Asp Ser 
1               

<210> 3
<211> 6
<212> PRT
<213> Artificial Sequence


<220> 
<223> Smooth muscle cell adhesion

<400> 3
Lys Gln Ala Gly Asp Val 
1               5       

<210> 4
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<223> Cell adhesion

<400> 4
Tyr Ile Gly Ser Arg 
1               5   

<210> 5
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Endothelial cell adhesion

<400> 5
Arg Glu Asp Val 
1               

<210> 6
<211> 15
<212> PRT
<213> Artificial Sequence


<220> 
<223> Cell adhesion (osteoblasts) P-15

<400> 6
Gly Thr Pro Gly Pro Gln Gly Ile Ala Gly Gln Arg Gly Val Val 
1               5                   10                  15  

<210> 7
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<223> Cell adhesion (osteoblasts)

<400> 7
Pro Asp Gly Glu Ala 
1               5   

<210> 8
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<223> Neurite extension

<400> 8
Ile Lys Val Ala Val 
1               5   

<210> 9
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Neurite extension

<400> 9
Arg Asn Ile Ala Glu Ile Ile Lys Asp Ile 
1               5                   10  

<210> 10
<211> 10
<212> PRT
<213> Artificial Sequence


<220> 
<223> Astrocyte adhesion

<400> 10
Lys His Ile Phe Ser Asp Asp Ser Ser Glu 
1               5                   10  

<210> 11
<211> 5
<212> PRT
<213> Artificial Sequence


<220> 
<223> Enhance elastic modulus of artificial extra cellular matrix (ECM)

<400> 11
Val Pro Gly Ile Gly 
1               5   

<210> 12
<211> 7
<212> PRT
<213> Artificial Sequence


<220> 
<223> Improve osteoblastic mineralization

<400> 12
Phe His Arg Arg Ile Lys Ala 
1               5           

<210> 13
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Osteoblast adhesion

<400> 13
Lys Arg Ser Arg 
1               

<210> 14
<211> 13
<212> PRT
<213> Artificial Sequence


<220> 
<223> Enhance neurite extension

<400> 14
Lys Phe Ala Lys Leu Ala Ala Arg Leu Tyr Arg Lys Ala 
1               5                   10              

<210> 15
<211> 14
<212> PRT
<213> Artificial Sequence


<220> 
<223> Enhance neurite extension

<400> 15
Lys His Lys Gly Arg Asp Val Ile Leu Lys Lys Asp Val Arg 
1               5                   10                  

<210> 16
<211> 8
<212> PRT
<213> Artificial Sequence


<220> 
<223> Enhance neurite extension

<400> 16
Tyr Lys Lys Ile Ile Lys Lys Leu 
1               5               

<210> 17
<211> 19
<212> PRT
<213> Artificial Sequence


<220> 
<223> Osteoinduction

<400> 17
Asn Ser Pro Val Asn Ser Lys Ile Pro Lys Ala Cys Cys Val Pro Thr 
1               5                   10                  15      
Glu Leu Ser 
            

<210> 18
<211> 4
<212> PRT
<213> Artificial Sequence


<220> 
<223> Collagenase mediated degradation

<400> 18
Ala Pro Gly Leu 
1               

<210> 19
<211> 9
<212> PRT
<213> Artificial Sequence


<220> 
<223> Elastase mediated degradation

<400> 19
Ala Ala Ala Ala Ala Ala Ala Ala Ala 
1               5                   

<210> 20
<211> 16
<212> PRT
<213> Artificial Sequence


<220> 
<223> Encourage cell-mediated proteolytic degradation, remodeling
      and/or bone regeneration (with RGD and BMP presentation in vivo)

<400> 20
Gly Cys Arg Asp Gly Pro Gln Gly Ile Trp Gly Gln Asp Arg Cys Gly 
1               5                   10                  15      



